The activated STAT3 pathway, in response to the binding of IL-6 secreted to its glycoprotein 130 (GP130) receptor, promotes tumour progression through the induction of various target genes involved in tumour cell survival, proliferation, angiogenesis, metastasis, and cell adhesion. Here, STAT3 is linked to neoplasm.